| SPAC | IPO Date | Role | Deal Size ($M) | Share | Book-Runner Credit ($M) | Volume Sold ($M) |
|---|---|---|---|---|---|---|
| Eucrates Biomedical Acquisition Corp. | 10/23/2020 | joint book-runner | 104.8 | 1/2 | 52.4 | 30.0 |
| 52.4 | 30.0 |
Credit for Book-Runner Credit ($M) is based on the total amount of the offering sold, including over-allotment. Full credit is awarded to the sole book-runner or split equally among joint book-runners.